LifeMD membership-based platform offering GLP-1s, urgent and primary care, and lab testing
Nahvi, R
This is especially true for semaglutide and sertraline, as both can have significant interactions with other medications
For example, semaglutide (Ozempic) (injectable) acts hormonally to reduce hunger and change reward-driven eating patterns, a different mechanism with larger average effects on weight in trials
Specifically, GLP-1 activity has been observed in areas like 8: The hypothalamus, which regulates appetite The brainstem, which connects gut signals to the brain The limbic system, including the nucleus accumbens and ventral tegmental area, which are involved in reward and cravings Through these pathways, GLP-1 medications may: Reduce food cravings and food noise Change how rewarding certain foods feel Lower motivation to seek out highly palatable foods There is also emerging interest in whether these effects extend beyond food
All of this hasnt stopped people from using the word Ozempic to label anything that they claim can lead to weight loss
